WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹298 Cr | ₹347 Cr | ₹284 Cr | ₹275 Cr | ₹283 Cr |
What is the latest Total Liabilities ratio of WANBURY ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹298 Cr |
Mar2022 | ₹347 Cr |
Mar2021 | ₹284 Cr |
Mar2020 | ₹275 Cr |
Mar2019 | ₹283 Cr |
How is Total Liabilities of WANBURY Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹298 Cr | -13.99 | |
Mar2022 | ₹347 Cr | 22.35 | |
Mar2021 | ₹284 Cr | 2.98 | |
Mar2020 | ₹275 Cr | -2.60 | |
Mar2019 | ₹283 Cr | - |
Compare Total Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹499.3 Cr | -5.7% | 7.9% | 228.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -5.7% |
7.9% |
228.5% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses